期刊文献+

尼可胺对H22肝癌荷瘤小鼠的放射增敏作用 被引量:2

The Radiosensitizing Effects of NiKeAn on H22 Hepatoma-Bearing Mice
下载PDF
导出
摘要 目的:探讨尼可胺对荷H22肝癌小鼠的放射增敏作用。方法:建立H22肝癌小鼠模型,按照给药和照射的不同,分为空白对照组、单纯照射组、阳性对照(烟酰胺、甘氨双唑钠)组、尼可胺(高、中、低)组。经照射后,观察H22肝癌小鼠肿瘤生长情况,记录肿瘤照射后生长时间,计算肿瘤生长延缓时间及各组的增敏系数(EF)。照射后28d时处死小鼠,剥瘤称质量,计算抑瘤率。结果:尼可胺高、中、低组较单纯照射组均能增加辐射敏感性,抑制肿瘤的生长,且尼可胺高剂量组的增敏系数和抑瘤率均高于其母体化合物烟酰胺和甘氨双唑钠,差异均有统计学意义(均P<0.05或P<0.01)。结论:较高剂量的尼可胺对H22肝癌小鼠肿瘤生长有较强的抑制作用和放射增敏效果。 Objective:To investigate the radiosensitizing effects of NiKeAn on H22 hepatoma-bearing mice.Methods:The mouse hepatoma H22 model was established.The model mice were divided into blank control group,pure radiation group,positive control group and NiKeAn(high,medium and low doses)group.After mice were irradiated,the tumor growth was observed,the epigenetic tumor irradiation time was recorded,and the delay time of tumor growth and enhancement factor(EF)were calculated.After 28 days,mice were killed.Tumors were stripped and the inhibition rate was calculated.Results:The radiosensitizing effect and tumor-inhibition rate were more higher in NiKeAn(high,medium and low doses)group than those of pure radiation group.The enhancement factor and inhibition rate were higher in NiKeAn group(high dose) than those of sodium glycididazole group and nicotinamide group(P 0.05 or P 0.01).Conclusion:NiKeAn in a higher dose can inhibit the tumor growth,and has radiosensitizing effects on H22 hepatoma-bearing mice.
出处 《天津医药》 CAS 北大核心 2011年第5期442-444,共3页 Tianjin Medical Journal
基金 天津市科技计划项目(项目编号:09ZCKFSH)
关键词 肝肿瘤 辐射增敏药 剂量效应关系 药物 疾病模型 动物 小鼠 尼可胺 liver neoplasms carcinoma radiation-sensitizing agents dose-response relationship drug disease models animal mice NiKeAn
  • 相关文献

参考文献8

二级参考文献9

共引文献34

同被引文献13

  • 1周远大,陈康,何海霞,江舟,曾敏莉,杨辉.野马追一般药理作用实验研究[J].中国药房,2005,16(2):94-96. 被引量:15
  • 2顾菲,刘晓秋,韩英,赵艳芝,胡晓林,宋汝亮.肿瘤放疗增敏药9401号的细胞毒性和体外放射增敏作用[J].中国辐射卫生,2006,15(4):392-393. 被引量:7
  • 3Bussink J, Kaanders JH, Van der Kogel AJ. Clinical outcome and tumour microenvironmental effects of accelerated radiotherapy with carbogen and nicotinamide[J]. Acta Oncol, 1999,38 (7) : 875. 被引量:1
  • 4Fenton BM, Lord EM, Paoni SF, et al. Enhancement of tumor perfusion and oxygenation by carbogen and nicotinamide during single-and multifraction irradiation[J]. Radiat Res,2000,153(1) :75. 被引量:1
  • 5国家食品药品监督管理局苈物研究技术指导原则(2005年)[M].北京:中国医药科技出版社,2006:77-82. 被引量:1
  • 6Fenton BM, Lord EM, Paoni SF. Enhancement of tumor perfusionand oxygenation by carbogen and nicotinamide during single- andmultifraction irradiation. Radiat Res, 2000, 153( 1): 75-83. 被引量:1
  • 7Janssens GO, Rademakers SE, Terhaard CH, et al. Acceleratedradiotherapy with carbogen and nicotinamide for laryngeal cancer:results of a phase III randomized trial. J Clin Oncol, 2012, 30( 15):1777-1783. 被引量:1
  • 8Sharma PK, Dwarakanath BS, Varshney R. Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation ofredox sensitive ASKl-JNK/p38MAPK signaling in head and neckcancer cells. Free Radic Biol Med, 2012, 53(7): 1500-1513. 被引量:1
  • 9《化学药物非临床药代动力研究技术指导原则》课题研究组.化学药物非临床药代动力学研究技术指导原则.3版.北京:中国医药科技出版社,2005: 133-144. 被引量:1
  • 10赵阿津,刘晓秋,韩英.9401号药对小鼠皮肤放射反应试验[J].中国药理通讯,2009,26(2):79-79. 被引量:3

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部